Background/Aims: The success rate of endoscopic variceal ligation (EVL) is about 85-94%. There is only a few studies attempting to determine the cause of EVL failure, and to date, on-site rescue treatments remains unestablished. This study aimed to elucidate the risk factors for EVL failure and the effectiveness of on-site rescue treatment. Methods: Data of 454 patients who underwent emergency EVL at Chonnam National University Hospital were retrospectively analyzed. Enrolled patients were divided into two groups: the EVL success and EVL failure groups. EVL failures were defined as inability to ligate the varices due to poor endoscopic visual field, or failure of hemostasis after band ligation for the culprit lesion. Results: Forty-seven patients experienced EVL failure. In the multivariate analysis, male patients, initial hypovolemic shock, active bleeding on endoscopy, and history of previous EVL were independent risk factors for EVL failure. During endoscopic procedure, we came across the common causes of EVL failure, including unsuctioned varix due to previous EVL-induced scars followed by insufficient ligation of the stigmata and inability to ligate the varix due to poor endoscopic visual field. Endoscopic variceal obturation using N-butyl-2-cyanoacrylate (48.9%) was the most commonly used on-site rescue treatment method, followed by insertion of Sangstaken Blakemore tube (14.9%), and EVL retrial (12.8%). The rescue treatments successfully achieved hemostasis in 91.7% of those in the EVL failure group. Conclusions: The risk factors of EVL failure should be considered before performing EVL, and in case of such scenario, on-site rescue treatment is needed. (Korean J Gastroenterol 2018;72:188-196) 
INTRODUCTION
Acute variceal hemorrhage is considered an emergent situation, with an incidence of 5-15% and a 6-week mortality rate of about 20% in patients with cirrhosis. 1, 2 Rebleeding is reported to occur in as many as 60% of patients, with a mortality rate of 30% within the first two years after the initial bleeding episode. 3 The current approaches to manage esophageal varices or variceal hemorrhage are as follows: pharmacological therapy consisting of splanchnic vasoconstrictors; endoscopic therapies, such as endoscopic injection sclerotherapy (EIS) or endoscopic variceal ligation (EVL); shunting therapy, such as transjugular intrahepatic portosystemic shunting (TIPS); and liver transplantation. 2, 4, 5 Another report showed that acrylate glue injection was effective and safe for the treatment of EV bleeding, 6 with improved outcomes compared with EIS. 7 Baveno VI consensus recommended EVL as a standard endoscopic treatment for acute esophageal variceal bleeding, 8 due to its superiority compared with EIS with respect to the rebleeding rate, complications, and survival rate. [9] [10] [11] However, EVL is not always successful in controlling active variceal hemorrhage. The success rate of EVL is about 85-94%, 9, [12] [13] [14] and Chen et al. 15 have reported an EVL failure rate of 4.8%
in cases of acute EV hemorrhage.
The prognosis of patients with failed EVL is dismal; but only a few studies have addressed the risk factors for EVL failure, and currently, there is no optimal recommendation for the on-site management of EVL failure. If the risk factors for EVL failure can be identified, bleeding-related mortality can further be minimized. Therefore, this study was designed to investigate the risk factors and on-site rescue treatments for EVL failure.
SUBJECTS AND METHODS

Ethical considerations
The present study was conducted in accordance with the ethical guidelines of the Declaration of Helsinki. This study was approved by the Institutional Review Board of Chonnam National University Hospital (IRB No. CNUH-2018-034).
Patients and study protocol
This study was a retrospective case-control study. Germany) was mixed with ethiodized oil (Lipiodol; Guerbert, Roissy, France), which was then injected as a bolus dose of 0.5-2 mL, depending on the amount of bleeding.
Definitions
EVL failures were defined in two ways: 1) the inability to ligate the varices due to poor endoscopic visual field (e.g., massive bleeding or severe belching of the patient), or 2) failure of hemostasis after band ligation for the culprit lesion. The size of EV was classified as small and straight (form 1); enlarged and tortuous (form 2); or large and coil-shaped that occupied more than one-third of the lumen (form 3). 16 Bleeding-related death was defined as death within 6 weeks of the index bleeding episode. 17 Active rescue treatment was defined as on-site EVO, EVL retrial, combination treatment, or TIPS. Non-active rescue treatment was defined as SB tube insertion or medical treatment only. Success of active rescue treatment was defined as no bleeding-related death in patients after active rescue treatments.
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The Korean Journal of Gastroenterology Values are presented as mean±standard deviation or n (%). EVL, esophageal variceal ligation; HBV, hepatitis B virus; HCV, hepatitis C virus; F, form; CPT, Child-Pugh-Turcotte; MELD, model for end-stage liver disease; APRI, AST to platelet ratio index; EV, esophageal varix; SRH, stigmata of recent hemorrhage; PVT, portal vein thrombosis; HCC, hepatocellular carcinoma; Hb, hemoglobin; PLT, platelet.
Statistical analysis
All statistical analyses were performed using SPSS ver- Data that were included in the regression analysis are presented as the OR with 95% CI.
RESULTS
The baseline characteristics of the enrolled patients
The cohort was comprised of 386 men (85%) and 68
women (15% 15 reported an EVL failure rate of 4.8%
for acute EV hemorrhage; however, they failed to discuss the cause of EVL failure and the potential rescue treatments.
Another study reported that emergent endoscopic treatment failed to achieve hemostasis in 10-20% of patients. 18 Patients who did not achieve hemostasis are at an increased risk for experiencing exsanguination and death. If one endoscopic modality fails to control bleeding, it is reasonable to try a different treatment modality. However, data regarding a second on-site endoscopic treatment attempt are lacking.
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This study is unique in that the incidence rate, risk factors, and on-site rescue treatments of EVL failure were all comprehensively evaluated. EVL failure occurred in 10.4% of patients in the present study, which is consistent with the rates that were observed in other previous studies. 15, 18 We found that male patients, initial hypovolemic shock, active bleeding on endoscopy, and previous EVL history increased the risk for EVL failure. However, PVT, HCC, hemoglobin level, platelet count, prothrombin time index, aspartate aminotransferase to platelet ratio index score, and Child-Pugh-Turcotte score were
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In emergent EVL conditions, various factors, including hemodynamic instability, poor visual field due to massive blood clots, and poor cooperation by the patient may hinder EVL from being performed successfully. In our study, the most common cause of EVL failure was an unsuctioned esophageal varix due to previous EVL-induced scars. The EVL failure rate was the lowest in patients without a history of previous EVL, but increased with repetitive EVL sessions. According to these findings, we suggest that repeated EVL might increase the chance of EVL failure due to increased fibrosis of the esophageal mucosa. However, further studies are needed to confirm this finding.
Regarding the on-site rescue treatments, the most common However, the number of failed patients was not large enough to determine which rescue treatment was the most effective, and the rescue treatment modalities that were used in the present study were not randomly assigned. Thus, the most efficacious rescue treatment in the management of EVL failure remains unknown, and large, prospective, randomized studies are warranted.
Tissue adhesives, such as NBC, have been used to manage esophageal variceal bleeding, since they promote immediate obturation of the vessel after injection of NBC. 20 Cipolletta et al. 20 reported that EVO using NBC initially achieved hemostasis at a rate of 94.2% in patients with esophageal variceal bleeding. EIS is performed by an injection of sclerosant (ethanolamine or polidocanol) into the varix. One to 2 mL of sclerosant is injected at each site, with a total of 10-15 mL per session. EIS is reported to be effective in about 80-90%
for hemostasis in cases of EV bleeding. 18 However, previous studies showed that EVO may be more efficacious and safer than EIS for treating acute esophageal variceal hemorrhage.
Moreover, EVO improved the clinical outcomes, such as in-hospital mortality compared to EIS. 6, 7 Furthermore, EIS is more time-consuming compared to EVO in emergency condition.
According to these findings, we had performed EVO for rescue treatment in EVL failure cases. In our study, EVO as an on-site rescue therapy was safe and effective for hemostasis in 21/23 patients (91.3%). To date, the efficacy and safety of EVO in patients with failed EVL have not been fully evaluated.
This study is novel in that it showed that the on-site rescue EVO effectively achieved hemostasis in patients with failed EVL.
Balloon tamponade, as a single therapy, may control the initial variceal bleeding in >80% of patients. 21 However, hemostasis is transient, and it is associated with a high rate of complications (such as aspiration pneumonia, necrosis of the esophagus, or airway obstruction) and a mortality rate of 20%.
It is recommended that a balloon tamponade should only be used as a temporary bridge, and the treatment should not be continued for more than 24 hours. 8 Recently, esophageal self-expandable metallic stents have been shown to be more effective and safer than balloon tamponade; however, this study included a small number of patients.
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A recent study showed that salvage TIPS achieved hemostasis in 90-100% of patients, with a rebleeding rate of 6-16%, in-hospital mortality rate of 75%, and 30 day mortality rate of 15%. 23 Early TIPS should be considered at high risk of treatment failure according to the Baveno VI consensus. However, given that the rescue TIPS is still associated with high mortality, it is related to the development of hepatic encephalopathy in one-third of patients. 24 Patients with heart failure, multiple hepatic cysts, and uncontrolled systemic infection are contraindicated for TIPS;
and Child-Pugh-Turcotte score >14 points, encephalopathy, PVT, and HCC are relative contraindications. However, patients with contraindications for TIPS (e.g., CTP class C, PVT, and HCC) are at increased risk of recurrent EV bleeding.
Moreover, TIPS may necessitate the urgent transfer of hemodynamically unstable patients to a specialized liver center because appropriate interventional radiology expertise may not be present in every medical center. Therefore, pa-tients who are not eligible for early TIPS may benefit from on-site rescue treatments in case of EVL failure. In the present study, the success rate of emergent rescue TIPS was 33.3%, which was lower than the rate of 84% reported in other studies. 25 The reason for the low success rate might be due to the small number of patients who were included in our study and the hemodynamic instability of these patients.
The rate of bleeding-related death in the present study was 7%, which was lower than the rate of 15-20% reported in other studies. 26 In the present study, there was a tendency of higher bleeding-related death in the EVL failure group (12.8%) compared with the EVL success group (6.4%). We think that active rescue treatments, through which most bleeding were successfully controlled, might have reduced bleeding-related death in the EVL failure group.
The present study has some limitations. First, this is a retrospective study, which may lead to various biases, such as patient selection and information. Second, since this is a single-center study, the results cannot be generalized to other patient populations. Third, the number of patients with failure was not so large as to evaluate which rescue therapy is the most effective. Furthermore, the rescue treatments were not randomized and were dependent on the endoscopist's experience; therefore, there was a selection bias depending on the patient's situation. The most effective rescue treatment in the management of patients with EVL failure remains unknown.
In conclusion, risk stratification of EVL failure should be conducted before performing EVL, and active on-site rescue treatments should be undertaken in case of EVL failure.
